Friday, 10 Apr 2020

You are here

RheumNow Podcast - Despite Corona (3.6.20)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Register now for RheumNow Live

  1. Risk factors for severe cranial ischaemic complications (sCIC) in GCA studied in 295 pts - 61 developed sCIC. Vision complications increased with age & jaw claudication (OR 3.43); decreased with PMR Sxs & higher CRP. Afib independent predictor of stroke. https://t.co/8VoZoVGVIp
  2. ANA positivity very common with liver diseases - 91% in syst autoimmune dz, 93% in PBC, 49% Autoimmune hepatitis, 19% in HBV, 14% in HCV, 23.5% in Hepatocellular carcinoma; but few had ANA ≥ 1:320 (5 HCC, 2.5%HBV, 1.6% HCV). Patterns also varied. https://t.co/1wnr9sHjye
  3. NICE cost analysis of combination DMARDs vs Biologic/MTX in 205 RA pts shows combo DMARDS achieve similar clinical benefits more cheaply than high-cost biologics https://t.co/vEjQFPNHYx
  4. Study of 199 pts shows increased prevalence of obstructive sleep apnea (OSA) in rheumatoid arthritis pts (based on polysomnography) with moderate-to-severe OSA (AHI ≥ 15) in 23% https://t.co/tGGa8dGyrG
  5. 35,248 rheumatic patients with 16 years follow-up finds an increase in all cause mortality in fibromyalgia & widespread pain (RR 1.19-1.38), and also for RA (RR 1.52). FM deaths included accidents, diabetes, suicide and HTN disorders https://t.co/VP0DkvSJoY
  6. Johnston County OA Project (1999–2015) found 327/800 with Xray hand OA (rHOA) - they were older, more often white and female. Women were more likely than men to have incident HOA, particularly for DIP rOA. HOA more frequent in whites vs AA https://t.co/wdXlrNqsIG
  7. EPOSA - 5 european OA cohorts studied showing 27% had 1 or falls; 10% fell twice or more (recurrent faller). Risk was associated with knee OA (RR-1.55). Opioids and analgesics mediated the associations between clinical OA and (recurrent) falls. https://t.co/9g87cZSvRK
  8. Serum aldolase serves as a useful marker for diagnosis and assessment of disease activity in patients with adult-onset Still's disease. https://t.co/K1Z8uqLwML
  9. Vitamin D deficiency is associated with lumbar disc disease and LBP in postmenopausal women; moresoe w/ very low vitamin D concentration < 10 ng/mL - study of 232 postmenopausal women https://t.co/Kmu8nMOaf7
  10. U.S. FDA Accepts Regulatory Submission for Tanezumab, an NGF inhibitor, for Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis https://t.co/9NsESTnn4S
  11. Venom Peptide-Steroid Conjugate Effective in Collagen Induced Arthritis
  12. Airway Inflammation Drives Rheumatoid Risk
Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

Incubation Period for COVID-19

The incubation period for coronavirus disease 2019 (COVID-19) has important implications for surveillance and control activities. The Annals of Internal Medicine reports a pooled analysis of confirmed COVID-19 cases January 4, 2020 and February 24, 2020. The analyzed confirmed SARS-CoV-2 infection outside Hubei province, China.

COVID-19 Susceptibility: Why Do Some Become So Ill?

The differential susceptibility to COVID-19 infection is attributable to socioeconomic factors and genetic differences, that together with environmental factors, human-virus interactions, gender, perhaps blood type, and age-related senescence determine the immune response and the likelihood of developing disease.

NICE Guidelines on Managing Rheumatologic Conditions During COVID-19 Pandemic

On April 3rd, the National Institute for Health and Care Excellence (NICE) in the UK, published a rapid guideline for managing children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection.

RheumNow Podcast – Pandemic Numbers (4.3.20)

Dr. Jack Cush reviews the news on COVID-19 and FDA actions this past week. Be sure to check out:

CDC: Impact of Underlying Health Conditions Among COVID-19 Patients

The March 31 release of the Morbidity and Mortality Weekly Report (MMWR) reviews the impact of several key comorbidities, most commonly diabetes mellitus, chronic lung disease, and cardiovascular disease, as cofactors leading to worse outcomes with COVID-19 infections.  Below are experts from that report.